Company / Current Liabilities
PALVELLA THERAPEUTICS, INC. Current Liabilities History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$12.0M
FY2024
5-year range
$2.4M / $50.6M
FY2020-FY2024
Trend
+410.1%
vs FY2023
Sector context
#204 of 213
Health Care
What the data says
Current Liabilities changed +410% YoY in FY2024, a notable deviation from the 9-year average annual change of +112%.
Based on SEC 10-K filings.
$12M in FY2024 with a 5-year CAGR of -14.9%.
Improved from $37M to $12M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -38.0%
- 5-Year CAGR
- -14.9%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 213This company $12.0M Sector average $1.6B
▼
-99.2% below sector average
Key checks
Key Insights
- 5-year CAGR of -14.9%, indicating a declining trend.
- In FY2024, current liabilities increased 410.1% year-over-year.
- Ranks #204 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $12.0M | +410.1% |
| FY2023 | $2.4M | -93.5% |
| FY2022 | $36.6M | -27.6% |
| FY2021 | $50.6M | +128.3% |
| FY2020 | $22.1M | -18.0% |
| FY2019 | $27.0M | -43.8% |
| FY2018 | $48.1M | +5.0% |
| FY2017 | $45.8M | +446.2% |
| FY2016 | $8.4M | +199.5% |
| FY2015 | $2.8M | -20.5% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026